New Delhi: The Indian patent office has rejected a drug company's claim to patent the syrup form of nevirapine.
Nevirapine is a crucial drug to treat AIDS. If the patent had been accepted, poor children living with AIDS, who are too small to swallow tablets, would not have had access to this critical drug.
This decision is also significant because of the message it sends to all companies waiting to patent their drugs, especially those meant to treat HIV/AIDS.
Nevirapine is a crucial drug to treat AIDS. If the patent had been accepted, poor children living with AIDS, who are too small to swallow tablets, would not have had access to this critical drug.
This decision is also significant because of the message it sends to all companies waiting to patent their drugs, especially those meant to treat HIV/AIDS.
COMMENTS
Advertisement
Windows Computers Lead To 'Blue Screen Of Death' Due To CrowdStrike Error Massive Worldwide Microsoft Outage: Flights, Markets, Stock Exchange Down Microsoft 'Blue Screen Of Death' Outage: Full List Of Services Hit In India Study Abroad: Top 10 Management Universities In United Kingdom "Reason Identified, Updates Released": India On Massive Microsoft Outage UPSC Cracks Down, Says Puja Khedkar Faked Identity, Parents' Name, Address Track Latest News Live on NDTV.com and get news updates from India and around the world.